Cite
APA Citation
Le Page, E., Veillard, D., Laplaud, D. A., Hamonic, S., Wardi, R., Lebrun, C., Zagnoli, F., Wiertlewski, S., Deburghgraeve, V., Coustans, M., Edan, G., , , & , (2015). oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial. Lancet, 386(9997), 974–981. http://access.bl.uk/ark:/81055/vdc_100042385449.0x000036